Detalles de la búsqueda
1.
Effects of Body Mass and Age on the Pharmacokinetics of Subcutaneous or Hyaluronidase-facilitated Subcutaneous Immunoglobulin G in Primary Immunodeficiency Diseases.
J Clin Immunol
; 43(8): 2127-2135, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37773562
2.
Monocarboxylate Transporters (SLC16): Function, Regulation, and Role in Health and Disease.
Pharmacol Rev
; 72(2): 466-485, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32144120
3.
Treatment of γ-Hydroxybutyrate (GHB) Overdose with the GABAB Antagonist SGS742.
J Pharmacol Exp Ther
; 2022 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35504663
4.
Treatment of γ-Hydroxybutyric Acid and γ-Butyrolactone Overdose with Two Potent Monocarboxylate Transporter 1 Inhibitors, AZD3965 and AR-C155858.
J Pharmacol Exp Ther
; 370(1): 84-91, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31010842
5.
Prediction of the Effects of Renal Impairment on Clearance for Organic Cation Drugs that Undergo Renal Secretion: A Simulation-Based Study.
Drug Metab Dispos
; 46(5): 758-769, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29490902
6.
Effects of renal impairment on transporter-mediated renal reabsorption of drugs and renal drug-drug interactions: A simulation-based study.
Biopharm Drug Dispos
; 39(4): 218-231, 2018 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-29635775
7.
Effect of chronic γ-hydroxybutyrate (GHB) administration on GHB toxicokinetics and GHB-induced respiratory depression.
Am J Drug Alcohol Abuse
; 43(6): 686-693, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28662343
8.
Population pharmacokinetics of immunoglobulin G after intravenous, subcutaneous, or hyaluronidase-facilitated subcutaneous administration in immunoglobulin-naive patients with primary immunodeficiencies.
Int Immunopharmacol
; 128: 111447, 2024 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38185032
9.
Integrated population pharmacokinetics of immunoglobulin G following intravenous or subcutaneous administration of various immunoglobulin products in patients with primary immunodeficiencies.
Int Immunopharmacol
; 113(Pt A): 109331, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36461591
10.
Simulation-Based Analysis of the Impact of Renal Impairment on the Pharmacokinetics of Highly Metabolized Compounds.
Pharmaceutics
; 11(3)2019 Mar 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30832339
11.
Corrigendum to "Integrated population pharmacokinetics of immunoglobulin G following intravenous or subcutaneous administration of various immunoglobulin products in patients with primary immunodeficiencies" [Int. Immunopharmacol. 113(Part A) (2022) 109331].
Int Immunopharmacol
; 114: 109555, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36527876
12.
γ-Hydroxybutyric Acid (GHB) Pharmacokinetics and Pharmacodynamics: Semi-Mechanistic and Physiologically Relevant PK/PD Model.
AAPS J
; 19(5): 1449-1460, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28653244
13.
The Drug of Abuse Gamma-Hydroxybutyric Acid Exhibits Tissue-Specific Nonlinear Distribution.
AAPS J
; 20(1): 21, 2017 12 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-29280004
Resultados
1 -
13
de 13
1
Próxima >
>>